Incidence (%) of most commonly reported treatment emergent adverse events (occurring with an incidence of at least 8% or a difference >5% between treatment groups)
| Pramipexole (n=34) | Placebo (n=44) | |
|---|---|---|
| Fatigue | 29.4 | 4.5 |
| Dyskinesia | 14.7 | 4.5 |
| Insomnia | 4.7 | 9.1 |
| Agitation | 11.8 | 6.8 |
| Vivid dreams | 11.8 | 0.0 |
| Postural hypotension | 8.8 | 2.3 |
| Cramps | 8.8 | 4.5 |
| Hypotension | 8.8 | 4.5 |
| Ataxia | 8.8 | 4.5 |
| Nausea | 8.8 | 6.8 |
| Increased sweating | 8.8 | 6.8 |
| Headache | 5.9 | 18.2 |
| Visual hallucinations | 5.9 | 0.0 |
| Abnormal lacrimation | 5.9 | 0.0 |
| Renal calculus | 5.9 | 0.0 |
| Nocturia | 5.9 | 0.0 |
| Somnolence | 5.9 | 9.1 |
| Dizziness | 2.9 | 27.3 |
| Aggravated parkinsonism | 2.9 | 13.4 |
| Back pain | 0.0 | 6.8 |